clinical trials for semaglutide Live Updates on Semaglutide's Current and Future Uses Semaglutide 2·4 mg once a

GLP-1 receptor agonists are used for type 2 diabetes and weight loss, and mimic the way the naturally occurring hormone, GLP-1, acts in the body

I surveyed 90+ people on how GLP-1 messaging has affected their body image, mental health, and daily life

The 30-second spot was developed in-house.

Beyond GLP-1: The next wave of incretin-based obesity treatments GIP/GLP-1 dual agonists (e.g., #Tirzepatide) weight loss vs

This review examines their clinical relevance, efficacy, and accessibility in Wichita, Kansas, providing an evidence-based assessment for informed decision-making

At Med 44, we offer medical weight loss and maintenance programs customized for each patient